NYSE ARCA | ETF
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities ofU. S. health care companies.
The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector.
The fund will typically invest in 50 " 100 health care companies.
The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.98% |
| ARQT | Arcutis Biotherapeutics Inc | Healthcare | Biotechnology | 6.88% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 5.86% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 5.71% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.86% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 4.65% |
| ALGN | Align Technology Inc | Healthcare | Medical Devices | 4.64% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 4.57% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 4.55% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.38% |
| NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 3.70% |
| SWAV | Shockwave Medical Inc | Healthcare | Medical Devices | 3.58% |
| VGG1110E1079 | BIOHAVEN LTD | 3.24% | ||
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.03% |
| RHHBY | Roche Holding Ltd ADR | Healthcare | Drug Manufacturers - General | 2.94% |
| PCT | Purecycle Technologies Holdings Corp | Industrials | Pollution & Treatment Controls | 2.89% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.78% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.72% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 2.62% |
| MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | 2.54% |